BPC-157 (Oral / Arginate Salt)
Healing & Recovery Peptide (Oral)researchAlso known as: BPC-157 Oral, BPC-157 Arginate, BPC Capsules, Oral Body Protection Compound
The oral formulation of BPC-157 using the arginate salt form, designed for convenient capsule administration targeting gut healing and systemic effects without injection.
Overview
BPC-157 Oral refers to the arginate salt form of BPC-157, specifically formulated for oral administration in capsule form. Unlike most peptides that are destroyed by stomach acid and digestive enzymes, BPC-157 is uniquely stable in gastric juice — it was originally isolated from gastric secretions. The arginate salt form further enhances oral stability and bioavailability. Oral BPC-157 is particularly popular for gut-related conditions (IBS, leaky gut, ulcers, GERD) as it directly contacts the gastrointestinal lining. However, it also provides systemic effects as BPC-157 is absorbed and distributed throughout the body. The oral form has become increasingly popular as a needle-free alternative, especially for gut health protocols. While injectable BPC-157 may be superior for localized musculoskeletal injuries, oral administration is preferred for GI conditions and general systemic healing.
Mechanism of Action
Same core mechanisms as injectable BPC-157, with direct GI tract contact: (1) Direct cytoprotective effects on gastric and intestinal mucosa upon contact; (2) Upregulates EGF, VEGF, and FGF receptors in gut epithelial cells; (3) Promotes tight junction protein expression for gut barrier repair; (4) Modulates nitric oxide system locally in the GI tract; (5) Absorbed systemically for tendon, ligament, and other tissue healing; (6) Counteracts NSAID and alcohol damage to gastric lining; (7) Arginate salt form enhances peptide stability through gastric transit.
Molecular Formula
C62H98N16O22 (BPC-157) + C6H14N4O2 (L-Arginine salt)
Molecular Weight
~1593 g/mol (BPC-157 arginate salt)
Sequence
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (arginate salt form)
Dosage Protocols
Dose Range
250mcg – 500mcg
Frequency
Twice daily
Route
oral (capsule)
Cycle Length
6-12 weeks
Take on an empty stomach for direct gut contact. Morning and evening dosing. Can be combined with probiotics (taken at different times).
Source: Gastroenterology research protocols
🧮 Personalized Dosage Calculator
💰 Estimated Pricing
Typical Supply
500mcg capsules, 60ct
Last Updated
2026-02
Oral stable form of BPC-157 (arginine salt). Telehealth clinics: $80-150/mo. Research vendors: $50-90/bottle.
⚠️ Prices are estimates based on publicly available data and may vary significantly by vendor, location, and prescription status. This is not medical or financial advice.
Side Effects
| Effect | Severity |
|---|---|
| Nausea | mild |
| Mild GI discomfort | mild |
| Dizziness | mild |
Pros & Cons
No injections required — convenient capsule form
Direct contact with GI lining makes it ideal for gut healing protocols
BPC-157 is uniquely stable in gastric juice — one of few peptides effective orally
Can provide systemic healing effects through oral absorption
Lower systemic bioavailability compared to subcutaneous injection
Not ideal for localized musculoskeletal injuries where injection near the site is preferred
Capsule quality and actual peptide content vary significantly between suppliers
Higher doses needed for systemic effects increases cost
Research Studies
🩸 Blood Work
No specific bloodwork requirements reported for this peptide. General health panels are always recommended before starting any peptide protocol.
Legal Status
Not FDA-approved. Available through compounding pharmacies and research chemical suppliers. Some companies sell BPC-157 capsules as supplements (regulatory gray area). WADA banned.
Readers Also Viewed
Semaglutide
99An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management, producing significant weight loss of 15-17% body weight in clinical trials.
BPC-157
98A 15-amino acid synthetic peptide derived from human gastric juice that promotes healing of tendons, ligaments, muscles, gut lining, and other tissues through multiple regenerative pathways.
Tirzepatide
97A first-in-class dual GIP/GLP-1 receptor agonist that produces up to 22.5% body weight loss, approved for type 2 diabetes and obesity management.
CJC-1295 + Ipamorelin (Combo)
95The most popular growth hormone peptide combination, pairing a GHRH analog (CJC-1295) with a ghrelin mimetic (Ipamorelin) for synergistic GH release with minimal side effects.
Related Peptides
Semaglutide
An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management, producing significant weight loss of 15-17% body weight in clinical trials.
BPC-157
A 15-amino acid synthetic peptide derived from human gastric juice that promotes healing of tendons, ligaments, muscles, gut lining, and other tissues through multiple regenerative pathways.
Tirzepatide
A first-in-class dual GIP/GLP-1 receptor agonist that produces up to 22.5% body weight loss, approved for type 2 diabetes and obesity management.
CJC-1295 + Ipamorelin (Combo)
The most popular growth hormone peptide combination, pairing a GHRH analog (CJC-1295) with a ghrelin mimetic (Ipamorelin) for synergistic GH release with minimal side effects.